Last 12 months
Inside the activity.
2 purchase rows · 112 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 1 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 26 |
| Jun 2026 | 0 | 13 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 56 |
| Sep 2026 | 0 | 12 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 27, 2020 Filed May 28, 2020 21:56 UTC |
ARNOLD FRANCESDirector
|
GrantCommon Stock | 963 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018074 · form4.xml · nonDerivative · entry 1 ARNOLD FRANCES · CIK 0001665419 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,917 F1 · security: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date. Read SEC document |
| May 26, 2020 Filed May 28, 2020 22:20 UTC |
SAMAD SAMSVP and CFO
|
SaleCommon Stock | 1,356 | $360.00 | $488,160.00 |
DisclosureSEC source: 0001127602-20-018090 · form4.xml · nonDerivative · entry 1 SAMAD SAM · CIK 0001694295 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,879 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| May 26, 2020 Filed May 28, 2020 21:59 UTC |
DORSA CAROLINEDirector
|
Tax withholdingCommon Stock | 519 | $354.41 | $183,938.79 |
DisclosureSEC source: 0001127602-20-018075 · form4.xml · nonDerivative · entry 1 DORSA CAROLINE · CIK 0001181174 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,042 Read SEC document |
| May 20, 2020 Filed May 21, 2020 20:51 UTC |
TOUSI SUSAN HSVP Product Development
|
SaleCommon Stock | 300 | $350.00 | $105,000.00 |
DisclosureSEC source: 0001127602-20-017566 · form4.xml · nonDerivative · entry 1 TOUSI SUSAN H · CIK 0001791938 · SVP Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,754 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| May 19, 2020 Filed May 20, 2020 22:48 UTC |
FLATLEY JAY TDirector
|
SaleCommon Stock | 4,000 | $342.34 | $1,369,360.00 |
DisclosureSEC source: 0001127602-20-017421 · form4.xml · nonDerivative · entry 1 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,970 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| May 18, 2020 Filed May 20, 2020 22:50 UTC |
SAMAD SAMSVP and CFO
|
SaleCommon Stock | 1,357 | $340.00 | $461,380.00 |
DisclosureSEC source: 0001127602-20-017422 · form4.xml · nonDerivative · entry 1 SAMAD SAM · CIK 0001694295 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,235 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| May 12, 2020 Filed May 13, 2020 22:08 UTC |
TOUSI SUSAN HSVP Product Development
|
SaleCommon Stock | 600 | $325.00 | $195,000.00 |
DisclosureSEC source: 0001127602-20-016472 · form4.xml · nonDerivative · entry 1 TOUSI SUSAN H · CIK 0001791938 · SVP Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,054 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:04 UTC |
OSTADAN OMEADSVP Mktg, Prod & Strat Plan
|
SaleCommon Stock | 2,140 | $315.13 | $674,369.43 |
DisclosureSEC source: 0001127602-20-016467 · form4.xml · nonDerivative · entry 1 OSTADAN OMEAD · CIK 0001642678 · SVP Mktg, Prod & Strat Plan 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,172 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| May 11, 2020 Filed May 13, 2020 21:57 UTC |
ARNOLD FRANCESDirector
|
SaleCommon Stock | 1,503 | $309.11 | $464,592.33 |
DisclosureSEC source: 0001127602-20-016461 · form4.xml · nonDerivative · entry 1 ARNOLD FRANCES · CIK 0001665419 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,954 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| May 05, 2020 Filed May 7, 2020 21:57 UTC |
FLATLEY JAY TDirector
|
SaleCommon Stock | 3,000 | $310.37 | $931,110.00 |
DisclosureSEC source: 0001127602-20-015822 · form4.xml · nonDerivative · entry 1 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,970 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| May 01, 2020 Filed May 5, 2020 23:01 UTC |
Van Oene MarkSVP Chief Commercial Officer
|
SaleCommon Stock | 100 | $316.86 | $31,685.60 |
DisclosureSEC source: 0001127602-20-015514 · form4.xml · nonDerivative · entry 2 Van Oene Mark · CIK 0001707477 · SVP Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,130 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F3 · price: Weighted average sale price representing 100 shares sold ranging from $316.82 to $316.86 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| May 01, 2020 Filed May 5, 2020 23:01 UTC |
Van Oene MarkSVP Chief Commercial Officer
|
SaleCommon Stock | 525 | $316.82 | $166,330.50 |
DisclosureSEC source: 0001127602-20-015514 · form4.xml · nonDerivative · entry 1 Van Oene Mark · CIK 0001707477 · SVP Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,230 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · price: Weighted average sale price representing 525 shares sold ranging from $315.27 to $315.715 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| May 01, 2020 Filed May 5, 2020 22:35 UTC |
deSouza Francis ADirector · President and CEO
|
SaleCommon Stock | 186 | $316.68 | $58,902.48 |
DisclosureSEC source: 0001127602-20-015506 · form4.xml · nonDerivative · entry 10 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,158 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F11 · price: Weighted average sale price representing 186 shares sold ranging from $316.16 to $317.16 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| May 01, 2020 Filed May 5, 2020 22:35 UTC |
deSouza Francis ADirector · President and CEO
|
SaleCommon Stock | 134 | $315.69 | $42,302.46 |
DisclosureSEC source: 0001127602-20-015506 · form4.xml · nonDerivative · entry 9 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,344 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F10 · price: Weighted average sale price representing 134 shares sold ranging from $315.12 to $315.98 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| May 01, 2020 Filed May 5, 2020 22:35 UTC |
deSouza Francis ADirector · President and CEO
|
SaleCommon Stock | 99 | $313.87 | $31,073.13 |
DisclosureSEC source: 0001127602-20-015506 · form4.xml · nonDerivative · entry 8 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,478 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F9 · price: Weighted average sale price representing 99 shares sold ranging from $313.79 to $313.94 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| May 01, 2020 Filed May 5, 2020 22:35 UTC |
deSouza Francis ADirector · President and CEO
|
SaleCommon Stock | 232 | $311.88 | $72,356.16 |
DisclosureSEC source: 0001127602-20-015506 · form4.xml · nonDerivative · entry 7 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,577 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F8 · price: Weighted average sale price representing 232 shares sold ranging from $311.43 to $312.29 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| May 01, 2020 Filed May 5, 2020 22:35 UTC |
deSouza Francis ADirector · President and CEO
|
SaleCommon Stock | 89 | $310.57 | $27,640.73 |
DisclosureSEC source: 0001127602-20-015506 · form4.xml · nonDerivative · entry 6 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,809 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F7 · price: Weighted average sale price representing 89 shares sold ranging from $310.42 to $310.78 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| May 01, 2020 Filed May 5, 2020 22:35 UTC |
deSouza Francis ADirector · President and CEO
|
SaleCommon Stock | 100 | $309.60 | $30,960.00 |
DisclosureSEC source: 0001127602-20-015506 · form4.xml · nonDerivative · entry 5 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,898 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F6 · price: Weighted average sale price representing 100 shares sold ranging from $309.22 to $309.94 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| May 01, 2020 Filed May 5, 2020 22:35 UTC |
deSouza Francis ADirector · President and CEO
|
SaleCommon Stock | 200 | $308.40 | $61,680.00 |
DisclosureSEC source: 0001127602-20-015506 · form4.xml · nonDerivative · entry 4 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,998 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F5 · price: Weighted average sale price representing 200 shares sold ranging from $308.21 to $308.70 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| May 01, 2020 Filed May 5, 2020 22:35 UTC |
deSouza Francis ADirector · President and CEO
|
SaleCommon Stock | 495 | $307.35 | $152,138.25 |
DisclosureSEC source: 0001127602-20-015506 · form4.xml · nonDerivative · entry 3 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,198 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F4 · price: Weighted average sale price representing 495 shares sold ranging from $307.12 to $307.81 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| May 01, 2020 Filed May 5, 2020 22:35 UTC |
deSouza Francis ADirector · President and CEO
|
SaleCommon Stock | 1,276 | $306.46 | $391,042.96 |
DisclosureSEC source: 0001127602-20-015506 · form4.xml · nonDerivative · entry 2 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,693 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F3 · price: Weighted average sale price representing 1,276 shares sold ranging from $305.98 to $306.98 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| May 01, 2020 Filed May 5, 2020 22:35 UTC |
deSouza Francis ADirector · President and CEO
|
SaleCommon Stock | 189 | $305.41 | $57,722.49 |
DisclosureSEC source: 0001127602-20-015506 · form4.xml · nonDerivative · entry 1 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,969 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · price: Weighted average sale price representing 189 shares sold ranging from $304.87 to $305.67 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| May 01, 2020 Filed May 5, 2020 22:22 UTC |
Dadswell CharlesSVP & General Counsel
|
SaleCommon Stock | 121 | $317.16 | $38,376.36 |
DisclosureSEC source: 0001127602-20-015502 · form4.xml · nonDerivative · entry 1 Dadswell Charles · CIK 0001575229 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,841 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| April 21, 2020 Filed Apr 22, 2020 20:52 UTC |
FLATLEY JAY TDirector
|
SaleCommon Stock | 3,000 | $310.77 | $932,310.00 |
DisclosureSEC source: 0001127602-20-014313 · form4.xml · nonDerivative · entry 1 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,970 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| April 20, 2020 Filed Apr 22, 2020 20:54 UTC |
SAMAD SAMSVP and CFO
|
SaleCommon Stock | 1,356 | $320.02 | $433,947.12 |
DisclosureSEC source: 0001127602-20-014314 · form4.xml · nonDerivative · entry 1 SAMAD SAM · CIK 0001694295 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,592 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · price: Weighted average sale price representing 1,356 shares sold ranging from $320.00 to $320.11 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| April 16, 2020 Filed Apr 20, 2020 21:41 UTC |
SAMAD SAMSVP and CFO
|
SaleCommon Stock | 1,697 | $300.00 | $509,100.00 |
DisclosureSEC source: 0001127602-20-014143 · form4.xml · nonDerivative · entry 1 SAMAD SAM · CIK 0001694295 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,948 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| April 16, 2020 Filed Apr 20, 2020 21:39 UTC |
Febbo Phillip G.SVP Chief Medical Officer
|
SaleCommon Stock | 173 | $300.00 | $51,900.00 |
DisclosureSEC source: 0001127602-20-014142 · form4.xml · nonDerivative · entry 1 Febbo Phillip G. · CIK 0001649245 · SVP Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,490 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| April 16, 2020 Filed Apr 20, 2020 21:37 UTC |
Van Oene MarkSVP Chief Commercial Officer
|
SaleCommon Stock | 1,250 | $300.22 | $375,275.00 |
DisclosureSEC source: 0001127602-20-014141 · form4.xml · nonDerivative · entry 1 Van Oene Mark · CIK 0001707477 · SVP Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,755 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · price: Weighted average sale price representing 1,250 shares sold ranging from $300.00 to $300.32 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| April 14, 2020 Filed Apr 16, 2020 20:25 UTC |
SAMAD SAMSVP and CFO
|
SaleCommon Stock | 249 | $292.54 | $72,842.46 |
DisclosureSEC source: 0001127602-20-013857 · form4.xml · nonDerivative · entry 1 SAMAD SAM · CIK 0001694295 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,645 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| April 07, 2020 Filed Apr 8, 2020 21:37 UTC |
FLATLEY JAY TDirector
|
SaleCommon Stock | 2,000 | $284.63 | $569,260.00 |
DisclosureSEC source: 0001127602-20-013508 · form4.xml · nonDerivative · entry 2 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,970 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| April 06, 2020 Filed Apr 7, 2020 20:26 UTC |
deSouza Francis ADirector · President and CEO
|
SaleCommon Stock | 3,000 | $275.00 | $825,000.00 |
DisclosureSEC source: 0001127602-20-013390 · form4.xml · nonDerivative · entry 1 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,158 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · price: Weighted average sale price representing 3,000 shares sold ranging from $275.00 to $275.02 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| April 05, 2020 Filed Apr 7, 2020 20:32 UTC |
Febbo Phillip G.SVP Chief Medical Officer
|
Tax withholdingCommon Stock | 92 | $278.01 | $25,576.92 |
DisclosureSEC source: 0001127602-20-013391 · form4.xml · nonDerivative · entry 1 Febbo Phillip G. · CIK 0001649245 · SVP Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,663 Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 20:38 UTC |
Dadswell CharlesSVP & General Counsel
|
SaleCommon Stock | 121 | $265.92 | $32,176.32 |
DisclosureSEC source: 0001127602-20-013162 · form4.xml · nonDerivative · entry 1 Dadswell Charles · CIK 0001575229 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,962 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| March 05, 2020 Filed Mar 9, 2020 21:14 UTC |
Hoyt Aimee LSVP, Chief People Officer
|
SaleCommon Stock | 417 | $273.95 | $114,237.15 |
DisclosureSEC source: 0001127602-20-009976 · form4.xml · nonDerivative · entry 1 Hoyt Aimee L · CIK 0001727683 · SVP, Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,689 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| March 03, 2020 Filed Mar 4, 2020 21:31 UTC |
FLATLEY JAY TDirector
|
SaleCommon Stock | 2,000 | $277.40 | $554,800.00 |
DisclosureSEC source: 0001127602-20-009412 · form4.xml · nonDerivative · entry 1 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,970 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:36 UTC |
deSouza Francis ADirector · President and CEO
|
SaleCommon Stock | 3,000 | $275.00 | $825,000.00 |
DisclosureSEC source: 0001127602-20-009429 · form4.xml · nonDerivative · entry 1 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,158 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:33 UTC |
Dadswell CharlesSVP & General Counsel
|
SaleCommon Stock | 1,686 | $268.02 | $451,881.72 |
DisclosureSEC source: 0001127602-20-009423 · form4.xml · nonDerivative · entry 1 Dadswell Charles · CIK 0001575229 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,083 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 22:04 UTC |
OSTADAN OMEADSVP Mktg, Prod & Strat Plan
|
SaleCommon Stock | 1,199 | $299.25 | $358,800.75 |
DisclosureSEC source: 0001127602-20-006721 · form4.xml · nonDerivative · entry 2 OSTADAN OMEAD · CIK 0001642678 · SVP Mktg, Prod & Strat Plan 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,312 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F3 · price: Weighted average sale price representing 1,199 shares sold ranging from $298.98 to $299.77 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 22:04 UTC |
OSTADAN OMEADSVP Mktg, Prod & Strat Plan
|
SaleCommon Stock | 601 | $298.10 | $179,158.10 |
DisclosureSEC source: 0001127602-20-006721 · form4.xml · nonDerivative · entry 1 OSTADAN OMEAD · CIK 0001642678 · SVP Mktg, Prod & Strat Plan 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,511 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · price: Weighted average sale price representing 601 shares sold ranging from $297.49 to $298.45 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| February 18, 2020 Filed Apr 8, 2020 21:37 UTC |
FLATLEY JAY TDirector
|
SaleCommon Stock | 3,000 | $299.00 | $897,000.00 |
DisclosureSEC source: 0001127602-20-013508 · form4.xml · nonDerivative · entry 1 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,970 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:06 UTC |
RAGUSA ROBERT PSVP, Global Quality & Ops
|
Exercise / conversionPerformance Shares · Derivative | 9,969 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005387 · form4.xml · derivative · entry 4 RAGUSA ROBERT P · CIK 0001222644 · SVP, Global Quality & Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,969 shares Expires 2019-12-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 2, 2016. F2 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 2, 2016. F2 · derivative.exercise_date: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 2, 2016. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:06 UTC |
RAGUSA ROBERT PSVP, Global Quality & Ops
|
Tax withholdingCommon Stock | 6,920 | $296.00 | $2,048,320.00 |
DisclosureSEC source: 0001127602-20-005387 · form4.xml · nonDerivative · entry 3 RAGUSA ROBERT P · CIK 0001222644 · SVP, Global Quality & Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,056 Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:06 UTC |
RAGUSA ROBERT PSVP, Global Quality & Ops
|
Exercise / conversionCommon Stock | 9,969 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005387 · form4.xml · nonDerivative · entry 2 RAGUSA ROBERT P · CIK 0001222644 · SVP, Global Quality & Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,976 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 2, 2016. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:06 UTC |
RAGUSA ROBERT PSVP, Global Quality & Ops
|
GrantCommon Stock | 4,985 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005387 · form4.xml · nonDerivative · entry 1 RAGUSA ROBERT P · CIK 0001222644 · SVP, Global Quality & Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,007 F1 · shares: Represents additional shares of stock awarded as a result of the Company achieving at least 150% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 2, 2016. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:15 UTC |
MCGINNIS KAREN KVP, Chief Accounting Officer
|
Exercise / conversionPerformance Shares · Derivative | 1,001 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005394 · form4.xml · derivative · entry 4 MCGINNIS KAREN K · CIK 0001188264 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,001 shares Expires 2019-12-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on Nov. 14, 2017. F2 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on Nov. 14, 2017. F2 · derivative.exercise_date: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on Nov. 14, 2017. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:15 UTC |
MCGINNIS KAREN KVP, Chief Accounting Officer
|
Tax withholdingCommon Stock | 536 | $296.00 | $158,656.00 |
DisclosureSEC source: 0001127602-20-005394 · form4.xml · nonDerivative · entry 3 MCGINNIS KAREN K · CIK 0001188264 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,206 Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:15 UTC |
MCGINNIS KAREN KVP, Chief Accounting Officer
|
Exercise / conversionCommon Stock | 1,001 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005394 · form4.xml · nonDerivative · entry 2 MCGINNIS KAREN K · CIK 0001188264 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,742 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on Nov. 14, 2017. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:15 UTC |
MCGINNIS KAREN KVP, Chief Accounting Officer
|
GrantCommon Stock | 501 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005394 · form4.xml · nonDerivative · entry 1 MCGINNIS KAREN K · CIK 0001188264 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,741 F1 · shares: Represents additional shares of stock awarded as a result of the Company achieving at least 150% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on Nov. 14, 2017. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:12 UTC |
Van Oene MarkSVP Chief Commercial Officer
|
Exercise / conversionPerformance Shares · Derivative | 3,431 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005393 · form4.xml · derivative · entry 8 Van Oene Mark · CIK 0001707477 · SVP Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,431 shares Expires 2019-12-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on May 22, 2017. F4 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on May 22, 2017. F4 · derivative.exercise_date: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on May 22, 2017. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:12 UTC |
Van Oene MarkSVP Chief Commercial Officer
|
Exercise / conversionPerformance Shares · Derivative | 8,210 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005393 · form4.xml · derivative · entry 7 Van Oene Mark · CIK 0001707477 · SVP Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,431 Underlying: Common Stock · 8,210 shares Expires 2019-12-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 2, 2016. F2 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 2, 2016. F2 · derivative.exercise_date: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 2, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.